News in brief: IBD patients show good response to COVID-19 vax; Colonoscopy cancellation in SGLT2i users; Colitis with Parkinson medication

Reassuring findings on IBD patients response to COVID-19 vaccination Patients with IBD taking biologics show good antibody responses to COVID-19 vaccination, according to US researchers. A study of 23 patients with Crohns Disease and 25 with ulcerative colitis  found that they had serological responses consistent with protective effects after receiving two-dose PfizerBioNTech or NIH-Moderna COVID-19 ...

Already a member?

Login to keep reading.

© 2021 the limbic